Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.66 |
| ▸ | NPC1 | O15118 | 8/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.66 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.66 |
| ▸ | PIM1 | P11309 | 1/20 | 0.66 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.66 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.66 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.66 |
| ▸ | FLT3 | P36888 | 1/20 | 0.66 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.66 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.66 |
| ▸ | PKM | P14618 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9750118 | 0.88 | NPC1 (0.81) | RAB9ANPC1SMN1; SMN2ADORA3PIM1 | |
| SCHEMBL10989725 | 0.81 | GAA (0.55) | RAB9ANPC1SMN1; SMN2ADORA3PIM1 | |
| SCHEMBL29940946 | 0.81 | RAB9A (0.62) | RAB9ANPC1SMN1; SMN2ADORA3PIM1 | |
| SCHEMBL11279908 | 0.81 | RAB9A (0.66) | RAB9ANPC1SMN1; SMN2ADORA3PIM1 | |
| SCHEMBL18469876 | 0.81 | RAB9A (0.66) | RAB9ANPC1SMN1; SMN2ADORA3PIM1 | |
| SCHEMBL438214 | 0.80 | RAB9A (0.70) | RAB9ANPC1SMN1; SMN2ADORA3PIM1 | |
| SCHEMBL30565139 | 0.79 | RAB9A (1.00) | RAB9ANPC1SMN1; SMN2ADORA3PIM1 | |
| SCHEMBL9317689 | 0.79 | RAB9A (1.00) | RAB9ANPC1SMN1; SMN2ADORA3PIM1 | |
| SCHEMBL13430977 | 0.79 | NPC1 (0.68) | RAB9ANPC1SMN1; SMN2ADORA3PIM1 | |
| SCHEMBL29128678 | 0.78 | RAB9A (0.66) | RAB9ANPC1SMN1; SMN2ADORA3PIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0646574-B1 | Ketonic indane derivatives, their preparation and therapeutic application thereof | INNOTHERA LAB SA (FR) | 1998-12-09 | — | — | EP | claimed |
| EP-0646574-A1 | Ketonic indane derivatives, their preparation and therapeutic application thereof | LABORATOIRE INNOTHERA Société Anonyme (FR) | 1995-04-05 | — | — | EP | claimed |
| CN-122010896-A | Bicyclol derivative, pharmaceutical composition thereof, preparation method and application thereof | 中国医学科学院药物研究所 | 2026-05-12 | — | — | CN | disclosed |
| US-20250243161-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | SENSORIUM THERAPEUTICS, INC. | 2025-07-31 | — | — | US | disclosed |
| US-12269800-B2 | Delivery of therapeutic alkaloid compounds | SENSORIUM THERAPEUTICS, INC. (US) | 2025-04-08 | — | — | US | disclosed |
| US-20250051277-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | SENSORIUM THERAPEUTICS, INC. | 2025-02-13 | — | — | US | disclosed |
| US-20240246910-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | SENSORIUM THERAPEUTICS, INC. | 2024-07-25 | — | — | US | disclosed |
| US-11999694-B2 | Delivery of therapeutic alkaloid compounds | SENSORIUM THERAPEUTICS, INC. (US) | 2024-06-04 | — | — | US | disclosed |
| US-20230159455-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | SENSORIUM THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
| US-20230159455-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | SENSORIUM THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
| US-20230159455-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | SENSORIUM THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
| US-5098462-A | Herbicides | SANDOZ LTD. (CH) | 1992-03-24 | — | — | US | disclosed |
| US-4451653-A | INSECTICIDCES | THE DOW CHEMICAL COMPANY (US) | 1984-05-29 | — | — | US | disclosed |
| US-4433148-A | CHEMICAL INTERMEDIATES FOR TRIAZOLYL PHOSPHORUS INSECTICIDWS | THE DOW CHEMICAL CO. (US) | 1984-02-21 | — | — | US | disclosed |
| US-4400516-A | PYRIDINE OR QUINOLINE SUBSTITUTED PESTICIDES | THE DOW CHEMICAL CO. (US) | 1983-08-23 | — | — | US | disclosed |
| US-4357327-A | Heterocyclic substituted triazolyl phosphorous compounds and their use as insecticides | THE DOW CHEMICAL CO. (US) | 1982-11-02 | — | — | US | disclosed |
| US-4357328-A | Heterocyclic substituted triazolyl phosphorous compounds and their use as insecticides | THE DOW CHEMICAL CO. (US) | 1982-11-02 | — | — | US | disclosed |
| EP-0010891-B1 | HETEROCYCLIC SUBSTITUTED TRIAZOLYL PHOSPHOROUS COMPOUNDS, INSECTICIDAL COMPOSITIONS CONTAINING THEM AND METHOD FOR CONTROLLING INSECTS | THE DOW CHEMICAL COMPANY (US) | 1982-09-01 | — | — | EP | disclosed |
| US-4298602-A | MITICIDES | THE DOW CHEMICAL COMPANY (US) | 1981-11-03 | — | — | US | disclosed |
| EP-0010891-A1 | Heterocyclic substituted triazolyl phosphorous compounds, insecticidal compositions containing them and method for controlling insects | THE DOW CHEMICAL COMPANY (US) | 1980-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051277-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | PNMT, HNMT, NNMT | RAB9A 571/4885NPC1 296/4885SMN1; SMN2 95/4885 |
| US-20250243161-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | PNMT, HNMT, NNMT | RAB9A 571/4885NPC1 296/4885SMN1; SMN2 95/4885 |
| US-20230159455-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | PNMT, HNMT, NNMT | RAB9A 571/4885NPC1 296/4885SMN1; SMN2 95/4885 |
| US-20240246910-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | PNMT, HNMT, NNMT | RAB9A 571/4885NPC1 296/4885SMN1; SMN2 95/4885 |
| US-12269800-B2 | Delivery of therapeutic alkaloid compounds | PNMT, HNMT, NNMT | RAB9A 571/4885NPC1 296/4885SMN1; SMN2 95/4885 |
| US-11999694-B2 | Delivery of therapeutic alkaloid compounds | PNMT, HNMT, NNMT | RAB9A 571/4885NPC1 296/4885SMN1; SMN2 95/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.